Novo Nordisk/NVO
$126.69
-0.47%About Novo Nordisk
Ticker
Sector
Trading on
Industry
CEO
Employees
Headquarters
Novo Nordisk Metrics
$432B
44.33
$2.87
0.41
$1.01
0.4%
Price and volume
Financial strength
Management effectiveness
Valuation
Growth
What the Analysts think about Novo Nordisk
Analyst Ratings
Price Targets
$126.69
$146.12
Novo Nordisk Financial Performance
Income Statement
Q1 24
QoQ growth
DKK 65B
-0.78%
DKK 25B
15.68%
38.87%
16.59%
Novo Nordisk Earnings Performance
Earnings per share (EPS)
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
DKK 4.39
DKK 4.32
DKK 5.00
DKK 4.91
-
DKK 4.32
DKK 4.41
DKK 5.00
DKK 4.48
DKK 5.14
1.62%
-2.09%
0.09%
9.55%
-
Upcoming events
FAQs
What’s the current market cap for Novo Nordisk stock?
What is the P/E ratio for Novo Nordisk stock?
Does Novo Nordisk stock pay dividends?
Yes, the Novo Nordisk (NVO) stock pays dividends to shareholders. As of May 09, 2024, the dividend rate is $1.00744 and the yield is 0.4%. Novo Nordisk has a payout ratio of 47.03% on a trailing twelve-month basis.
When is the next Novo Nordisk dividend payment date?
The next Novo Nordisk (NVO) dividend payment date is unconfirmed.
What is the beta indicator for Novo Nordisk?
Novo Nordisk (NVO) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Novo Nordisk stock price target?
The target price for Novo Nordisk (NVO) stock is $146.12, which is 15.34% above the current price of $126.69. This is an average based on projections from 8 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.